Emily is proud to help clients bridge clinical and commercial priorities to ensure that the right drugs make it to market for the right patients.

As leader of ZS’s pipeline and launch practice, Emily helps clients develop differentiated assets and build capabilities to effectively bring them to market. Emily is passionate about improving clinical and commercial collaboration so life sciences can bring the most value to the people they serve.

Since 2005, Emily has been advising pharmaceutical clients on pipeline marketing issues such as clinical trial design, forecasting, opportunity assessment, segmentation, positioning and messaging. She has worked across dozens of therapeutic areas, most prominently oncology, immunology and neuroscience.

Emily has worked across life sciences industries at ZS, including medtech, emerging pharma and large pharma. She has also spent time in analytics and insights at two pharmaceutical companies. Her prior role was leading the customer insights practice area at ZS where she developed innovative methodologies to champion the voice of the customer.

Emily holds a B.B.A. in accounting from the University of Wisconsin-Madison.